Brandon Couillard
Stock Analyst at Wells Fargo
(4.88)
# 306
Out of 4,534 analysts
688
Total ratings
61.6%
Success rate
17.9%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintained: Buy | $615 | $526.23 | +16.87% | 41 | Jul 14, 2026 | |
| GH Guardant Health | Maintained: Buy | $125 | $148.07 | -15.58% | 8 | Jul 2, 2026 | |
| TECH Bio-Techne | Maintained: Buy | $62 | $71.64 | -13.46% | 6 | Jun 26, 2026 | |
| A Agilent Technologies | Maintained: Buy | $165 → $160 | $130.26 | +22.83% | 55 | May 28, 2026 | |
| MLAB Mesa Laboratories | Rated: Hold | $94 | $96.67 | -2.76% | 14 | May 28, 2026 | |
| BIO Bio-Rad Laboratories | Maintained: Hold | $290 → $310 | $301.90 | +2.68% | 56 | May 22, 2026 | |
| BLLN BillionToOne | Maintained: Hold | $90 | $125.14 | -28.08% | 4 | May 22, 2026 | |
| WAT Waters | Maintained: Hold | $355 → $370 | $357.54 | +3.48% | 29 | May 14, 2026 | |
| NTRA Natera | Maintained: Hold | $215 → $220 | $262.63 | -16.23% | 4 | May 8, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $6 → $5.5 | $5.92 | -7.09% | 29 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 → $75 | $60.65 | +23.66% | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $240 → $212 | $201.11 | +5.41% | 52 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $190 → $180 | $145.49 | +23.72% | 29 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $21 | $38.37 | -45.27% | 11 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $10.66 | +31.33% | 18 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $107 → $110 | $106.44 | +3.34% | 38 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $55 | $56.17 | -2.08% | 40 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1,400 → $1,450 | $1,273.77 | +13.84% | 25 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $4.5 | $6.99 | -35.62% | 12 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $17 | $15.71 | n/a | 4 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $88 → $81 | $86.20 | n/a | 21 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $38 | $13.46 | n/a | 25 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $23 | $26.58 | n/a | 6 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $305 → $325 | $175.05 | n/a | 43 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $314.13 | n/a | 26 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $1.69 | n/a | 2 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 | $2.21 | n/a | 7 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $16 → $15 | $3.85 | n/a | 20 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $300 | $154.48 | n/a | 17 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $4.5 | $1.20 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $1.75 | $0.5049 | n/a | 11 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $59.11 | n/a | 1 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $40.48 | n/a | 5 | Nov 22, 2016 |
Thermo Fisher Scientific
Jul 14, 2026
Maintained: Buy
Price Target: $615
Current: $526.23
Upside: +16.87%
Guardant Health
Jul 2, 2026
Maintained: Buy
Price Target: $125
Current: $148.07
Upside: -15.58%
Bio-Techne
Jun 26, 2026
Maintained: Buy
Price Target: $62
Current: $71.64
Upside: -13.46%
Agilent Technologies
May 28, 2026
Maintained: Buy
Price Target: $165 → $160
Current: $130.26
Upside: +22.83%
Mesa Laboratories
May 28, 2026
Rated: Hold
Price Target: $94
Current: $96.67
Upside: -2.76%
Bio-Rad Laboratories
May 22, 2026
Maintained: Hold
Price Target: $290 → $310
Current: $301.90
Upside: +2.68%
BillionToOne
May 22, 2026
Maintained: Hold
Price Target: $90
Current: $125.14
Upside: -28.08%
Waters
May 14, 2026
Maintained: Hold
Price Target: $355 → $370
Current: $357.54
Upside: +3.48%
Natera
May 8, 2026
Maintained: Hold
Price Target: $215 → $220
Current: $262.63
Upside: -16.23%
Myriad Genetics
May 6, 2026
Maintained: Hold
Price Target: $6 → $5.5
Current: $5.92
Upside: -7.09%
May 5, 2026
Rated: Buy
Price Target: $155 → $75
Current: $60.65
Upside: +23.66%
Apr 22, 2026
Rated: Hold
Price Target: $240 → $212
Current: $201.11
Upside: +5.41%
Feb 25, 2026
Maintained: Buy
Price Target: $190 → $180
Current: $145.49
Upside: +23.72%
Feb 25, 2026
Maintained: Hold
Price Target: $18 → $21
Current: $38.37
Upside: -45.27%
Feb 13, 2026
Maintained: Buy
Price Target: $16 → $14
Current: $10.66
Upside: +31.33%
Feb 3, 2026
Maintained: Hold
Price Target: $107 → $110
Current: $106.44
Upside: +3.34%
Dec 15, 2025
Maintained: Buy
Price Target: $50 → $55
Current: $56.17
Upside: -2.08%
Dec 15, 2025
Maintained: Hold
Price Target: $1,400 → $1,450
Current: $1,273.77
Upside: +13.84%
Dec 15, 2025
Maintained: Buy
Price Target: $4 → $4.5
Current: $6.99
Upside: -35.62%
Mar 13, 2024
Maintained: Buy
Price Target: $21 → $17
Current: $15.71
Upside: n/a
Mar 6, 2024
Maintained: Hold
Price Target: $88 → $81
Current: $86.20
Upside: n/a
Feb 29, 2024
Maintained: Buy
Price Target: $36 → $38
Current: $13.46
Upside: n/a
Feb 9, 2024
Downgraded: Hold
Price Target: $32 → $23
Current: $26.58
Upside: n/a
Feb 1, 2024
Maintained: Buy
Price Target: $305 → $325
Current: $175.05
Upside: n/a
Aug 29, 2022
Maintained: Buy
Price Target: $200
Current: $314.13
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $13 → $11
Current: $1.69
Upside: n/a
Jun 18, 2021
Rated: Buy
Price Target: $26
Current: $2.21
Upside: n/a
Aug 6, 2020
Rated: Hold
Price Target: $16 → $15
Current: $3.85
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $280 → $300
Current: $154.48
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: $3.5 → $4.5
Current: $1.20
Upside: n/a
Jul 27, 2018
Reiterated: Buy
Price Target: $2 → $1.75
Current: $0.5049
Upside: n/a
May 31, 2017
Reiterated: Buy
Price Target: $116
Current: $59.11
Upside: n/a
Nov 22, 2016
Reiterated: Hold
Price Target: $26
Current: $40.48
Upside: n/a